Mettl8 Regulates Hippocampal Neural Stem Cell Proliferation and Neurogenesis via mTOR / 4E ‐ BP1 Signaling
CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)
DOI: 10.1002/cns.70953 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 24.05.2026. Verfasst von Jiamin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Neural Stem Cells, Hippocampus, Signal Transduction. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Guangdong Basic and Applied Basic Research Foundation, the Research Ability Enhancement Project of Guangzhou Medical University.
Abstract (Originalsprache)
Aims
Hippocampal neural stem cells (NSCs) proliferation and differentiation are crucial for neuroregeneration, but their regulation remains unclear. This study investigates the role of the RNA methyltransferase Mettl8 in NSCs' fate determination. Materials and Methods Stable Mettl8‐knockdown and overexpressing NSCs lines were generated via lentiviral transduction. Gene/protein expression was analyzed by qRT‐PCR, WB, and immunofluorescence. Proliferation and cell cycle were assessed using EdU assays and flow cytometry. Transcriptomic profiling was performed via RNA‐seq, and mechanistic validation was conducted with the mTOR inhibitor Rapamycin.
Results
Mettl8 expression was higher in differentiated neurons and astrocytes than in NSCs. Functionally, Mettl8 knockdown induced G0/G1 arrest, reduced Cyclin E, and suppressed proliferation, while its overexpression promoted proliferation. Conversely, Mettl8 loss increased neuronal (βIII‐Tubulin) and astrocytic (GFAP) marker expression, whereas overexpression impaired differentiation. Mechanistically, Mettl8 negatively regulated the Akt/mTOR/4E‐BP1 pathway. Knockdown activated this pathway, and Rapamycin reversed the enhanced mTOR/4E‐BP1 phosphorylation and neuronal differentiation caused by Mettl8 loss.
Conclusion
Mettl8 maintains NSCs' proliferative homeostasis and suppresses differentiation by fine‐tuning mTOR/4E‐BP1 signaling, revealing a potential therapeutic target for neuroregeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China.
- The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China.
- The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong Province, China.
- Scientific Research Center of Guangzhou Medical University, Guangzhou, Guangdong Province, China.
ORCID-Profile: Liping Xu, Ying Lyu, Aiguo Xuan
Förderung
- the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital
- Guangdong Basic and Applied Basic Research Foundation
- the Research Ability Enhancement Project of Guangzhou Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Xu, J., Xu, L., Li, Y., Kong, X., Ma, W., Xie, L., Lyu, Y., & Xuan, A. (2026). Mettl8 Regulates Hippocampal Neural Stem Cell Proliferation and Neurogenesis via mTOR / 4E ‐ BP1 Signaling. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70953
Vancouver
Xu J, Xu L, Li Y, Kong X, Ma W, Xie L, et al. Mettl8 Regulates Hippocampal Neural Stem Cell Proliferation and Neurogenesis via mTOR / 4E ‐ BP1 Signaling. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70953
BibTeX
@article{Xu2026,
author = {Xu, Jiamin and Xu, Liping and Li, Yang and Kong, Xuejian and Ma, Wenhui and Xie, Linjie and Lyu, Ying and Xuan, Aiguo},
title = {Mettl8 Regulates Hippocampal Neural Stem Cell Proliferation and Neurogenesis via mTOR / 4E ‐ BP1 Signaling},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/cns.70953}
}
EUVIMED